RxDoctor Payments Data

Shawn McGlew, PA

Physician Assistant · Augusta, MENPI 1417918665

Payments from drug & device makers

$785in general payments, 2019–2025

Across 35 payments — averaging $22.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tolmar, Inc.$157
  • Sumitomo Pharma America, Inc.$130
  • Pfizer$90
  • Endo Pharmaceuticals Inc.$56
  • Halozyme Inc$52
  • Endo USA, Inc.$50
  • plus $250 from 11 others

What the payments were for

  • Food & beverage$785100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$785 in reported general payments places this provider in the 90th percentile of 774 physician assistant providers in Maine.

See all physician assistant providers in Maine

Medicare billing

Part B allowed, 2024
$21,405
Medicare patients
259
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron238$190,986
GemtesaVibegron167$123,347
JatenzoTestosterone Undecanoate23$22,639
Mirabegron ErMirabegron19$9,872
Tamsulosin Hcl502$5,784
Oxybutynin Chloride ErOxybutynin Chloride146$4,315
Solifenacin Succinate40$2,533
Finasteride184$2,341
Desmopressin Acetate33$2,132
Estradiol32$1,758
Desmopressin AcetateDesmopressin (Nonrefrigerated)14$1,456
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst63$1,034
Alfuzosin Hcl ErAlfuzosin Hcl22$640
NitrofurantoinNitrofurantoin Macrocrystal16$560
Nystatin16$449

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$130$123,347167 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 774 physician assistant providers in Maine.

Other physician assistant in Augusta

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →